Biogen Idec makes $14.50 per share offer for Facet
07 September 2009
Sita Shah
Please Login to read the full article.
07 September 2009
Sita Shah
Biogen Idec has offered $14.50 per share in cash to acquire Facet Biotech. Facet has 24.5 million shares outstanding, so the deal is valued at around $356 million.
The offer represents a 64% premium over the closing price of Facet's stock on September 3rd. However Facet's share...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche lets money do the talking with hostile $5.7bn bid after Illumina negotiations fail
- 7th Annual Scrip Awards: Novartis, Jimenez, Burrill, Glenmark, ICON win
- Stockwatch: Stings in the bifurcating tail
- Cephalon drop on $225M Gemin X purchase as markets look for quicker pipeline hits
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
